Literature DB >> 31426123

Pre-transplant short telomeres are associated with high mortality risk after unrelated donor haematopoietic cell transplant for severe aplastic anaemia.

Youjin Wang1, Lisa J McReynolds1, Casey Dagnall2,3, Hormuzd A Katki4, Stephen R Spellman5, Tao Wang6,7, Belynda Hicks2,3, Neal D Freedman8, Kristine Jones2,3, Stephanie J Lee6,9, Sharon A Savage1, Shahinaz M Gadalla1.   

Abstract

Telomeres are essential for chromosomal stability and markers of biological age. We evaluated the effect of pre-transplant short (<10th percentile-for-age) or very short (<5th or <1st percentile-for-age) leucocyte telomere length on survival after unrelated donor haematopoietic cell transplantation (HCT) for acquired severe aplastic anaemia (SAA). Patient pre-transplant blood samples and clinical data were available at the Center for International Blood and Marrow Transplant Research. We used quantitative real time polymerase chain reaction to measure relative telomere length (RTL) in 490 SAA patients who received HCT between 1990 and 2013 (median age = 20 years). One hundred and twelve patients (22·86%) had pre-HCT RTL <10th percentile-for-age, with the majority below the 5th percentile (N = 80, 71·43%). RTL <10th percentile-for-age was associated with a higher risk of post-HCT mortality (hazard ratio [HR] = 1·78, 95% confidence interval [CI]=1·18-2·69, P = 0·006) compared with RTL ≥50th percentile; no survival differences were noted in longer RTL categories (P > 0·10). Time-dependent effects for post-HCT mortality were only observed in relation to very short RTL; HR comparing RTL <5th versus ≥5th percentile = 1·38, P = 0·15 for the first 12 months after HCT, and HR = 3·91, P < 0·0001, thereafter, P-heterogeneity = 0·008; the corresponding HRs for RTL <1st versus ≥1st percentile = 1·29, P = 0·41, and HR = 5·18, P < 0·0001, P-heterogeneity = 0·005. The study suggests a potential role for telomere length in risk stratification of SAA patients in regard to their HCT survival.
© 2019 British Society for Haematology and John Wiley & Sons Ltd.

Entities:  

Keywords:  haematopoietic cell transplantation; severe aplastic anaemia; survival; telomere lengths; unrelated donor

Mesh:

Year:  2019        PMID: 31426123      PMCID: PMC6980174          DOI: 10.1111/bjh.16153

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   8.615


  27 in total

1.  Telomere measurement by quantitative PCR.

Authors:  Richard M Cawthon
Journal:  Nucleic Acids Res       Date:  2002-05-15       Impact factor: 16.971

2.  Association between donor leukocyte telomere length and survival after unrelated allogeneic hematopoietic cell transplantation for severe aplastic anemia.

Authors:  Shahinaz M Gadalla; Tao Wang; Michael Haagenson; Stephen R Spellman; Stephanie J Lee; Kirsten M Williams; Jason Y Wong; Immaculata De Vivo; Sharon A Savage
Journal:  JAMA       Date:  2015-02-10       Impact factor: 56.272

3.  Effect of Recipient Age and Stem Cell Source on the Association between Donor Telomere Length and Survival after Allogeneic Unrelated Hematopoietic Cell Transplantation for Severe Aplastic Anemia.

Authors:  Shahinaz M Gadalla; Tao Wang; Casey Dagnall; Michael Haagenson; Stephen R Spellman; Belynda Hicks; Kristine Jones; Hormuzd A Katki; Stephanie J Lee; Sharon A Savage
Journal:  Biol Blood Marrow Transplant       Date:  2016-09-15       Impact factor: 5.742

4.  Association of telomere length of peripheral blood leukocytes with hematopoietic relapse, malignant transformation, and survival in severe aplastic anemia.

Authors:  Phillip Scheinberg; James N Cooper; Elaine M Sloand; Colin O Wu; Rodrigo T Calado; Neal S Young
Journal:  JAMA       Date:  2010-09-22       Impact factor: 56.272

5.  TINF2 mutations in children with severe aplastic anemia.

Authors:  Hong-Yan Du; Philip J Mason; Monica Bessler; David B Wilson
Journal:  Pediatr Blood Cancer       Date:  2009-05       Impact factor: 3.167

6.  Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita.

Authors:  Blanche P Alter; Gabriela M Baerlocher; Sharon A Savage; Stephen J Chanock; Babette B Weksler; Judith P Willner; June A Peters; Neelam Giri; Peter M Lansdorp
Journal:  Blood       Date:  2007-04-27       Impact factor: 22.113

7.  Real-time PCR assay for measurement of mouse telomeres.

Authors:  Ralph J Callicott; James E Womack
Journal:  Comp Med       Date:  2006-02       Impact factor: 0.982

8.  Diagnostic utility of telomere length testing in a hospital-based setting.

Authors:  Jonathan K Alder; Vidya Sagar Hanumanthu; Margaret A Strong; Amy E DeZern; Susan E Stanley; Clifford M Takemoto; Ludmila Danilova; Carolyn D Applegate; Stephen G Bolton; David W Mohr; Robert A Brodsky; James F Casella; Carol W Greider; J Brooks Jackson; Mary Armanios
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-20       Impact factor: 11.205

9.  The limitations of qPCR telomere length measurement in diagnosing dyskeratosis congenita.

Authors:  Shahinaz M Gadalla; Payal P Khincha; Hormuzd A Katki; Neelam Giri; Jason Y Y Wong; Stephen Spellman; Jack A Yanovski; Joan C Han; Immaculata De Vivo; Blanche P Alter; Sharon A Savage
Journal:  Mol Genet Genomic Med       Date:  2016-03-20       Impact factor: 2.183

10.  Telomere Length Calibration from qPCR Measurement: Limitations of Current Method.

Authors:  Youjin Wang; Sharon A Savage; Rotana Alsaggaf; Geraldine Aubert; Casey L Dagnall; Stephen R Spellman; Stephanie J Lee; Belynda Hicks; Kristine Jones; Hormuzd A Katki; Shahinaz M Gadalla
Journal:  Cells       Date:  2018-10-24       Impact factor: 6.600

View more
  4 in total

1.  Population Frequency of Fanconi Pathway Gene Variants and Their Association with Survival After Hematopoietic Cell Transplantation for Severe Aplastic Anemia.

Authors:  Lisa J McReynolds; Youjin Wang; Ashley S Thompson; Bari J Ballew; Jung Kim; Blanche P Alter; Belynda Hicks; Bin Zhu; Kristine Jones; Stephen R Spellman; Tao Wang; Stephanie J Lee; Sharon A Savage; Shahinaz M Gadalla
Journal:  Biol Blood Marrow Transplant       Date:  2020-01-23       Impact factor: 5.742

2.  Telomere length in hematopoietic cell transplant.

Authors:  Shahinaz M Gadalla
Journal:  Blood       Date:  2020-12-24       Impact factor: 22.113

3.  Haploidentical bone marrow transplantation in patients with relapsed or refractory severe aplastic anaemia in the USA (BMT CTN 1502): a multicentre, single-arm, phase 2 trial.

Authors:  Amy E DeZern; Mary Eapen; Juan Wu; Julie-An Talano; Melhem Solh; Blachy J Dávila Saldaña; Chatchada Karanes; Mitchell E Horwitz; Kanwaldeep Mallhi; Sally Arai; Nosha Farhadfar; Elizabeth Hexner; Peter Westervelt; Joseph H Antin; H Joachim Deeg; Eric Leifer; Robert A Brodsky; Brent R Logan; Mary M Horowitz; Richard J Jones; Michael A Pulsipher
Journal:  Lancet Haematol       Date:  2022-07-27       Impact factor: 30.153

4.  Short telomere length predicts nonrelapse mortality after stem cell transplantation for myelodysplastic syndrome.

Authors:  Mikko Myllymäki; Robert Redd; Christopher R Reilly; Wael Saber; Stephen R Spellman; Christopher J Gibson; Zhen-Huan Hu; Tao Wang; Esther H Orr; Jaclyn G Grenier; Maxine M Chen; David P Steensma; Corey Cutler; Immaculata De Vivo; Joseph H Antin; Donna Neuberg; Suneet Agarwal; R Coleman Lindsley
Journal:  Blood       Date:  2020-12-24       Impact factor: 22.113

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.